Tech Center 1600 • Art Units: 1647
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18142196 | Anti-Interleukin-4 Receptor (IL-4R) Antibody Formulations | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18352081 | METHODS AND COMPOSITIONS FOR PRODUCING TARGETED MICROBUBBLES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18303407 | DNA THERAPEUTIC ENCODING AN ANTIBODY OR ANTIGEN BINDING FRAGMENT | Non-Final OA | Entos Pharmaceuticals, Inc. |
| 18327402 | CLAUDIN 18.2 ANTIBODIES, METHODS OF MAKING THE SAME, AND USES THEREOF | Non-Final OA | Integral Molecular, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy